Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Dow
McKesson
McKinsey

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Droxidopa - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for droxidopa and what is the scope of freedom to operate?

Droxidopa is the generic ingredient in one branded drug marketed by Lundbeck Na Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for droxidopa. One supplier is listed for this compound.

Summary for droxidopa
Recent Clinical Trials for droxidopa

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lundbeck LLCPhase 4
William Ondo, MDPhase 4
St. Joseph's Hospital and Medical Center, PhoenixPhase 2

See all droxidopa clinical trials

Pharmacology for droxidopa
Physiological EffectIncreased Blood Pressure
Medical Subject Heading (MeSH) Categories for droxidopa

US Patents and Regulatory Information for droxidopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-003 Feb 18, 2014 RX Yes Yes   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-003 Feb 18, 2014 RX Yes Yes   Start Trial   Start Trial   Start Trial
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKesson
Dow
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.